 | • レポートコード：MRC2012B1615 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、子宮筋腫治療装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。子宮筋腫治療装置の種類別市場規模（手術技術、腹腔鏡技術、アブレーション技術、塞栓術技術）、用途別市場規模（侵襲的治療、低侵襲的治療、非侵襲的治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、Gynesonics、INSIGHTEC、Stryker Corporation、Lumenis、Boston Scientific Corporation、Shenzhen PRO HITU Medical、Hologic, Inc.、CooperSurgical Inc.、Chongqing Haifu Medical Technology ・地域別グローバル市場分析 2015年-2020年 ・子宮筋腫治療装置の北米市場（アメリカ、カナダ、メキシコ） ・子宮筋腫治療装置のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・子宮筋腫治療装置のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・子宮筋腫治療装置の南米市場（ブラジル、アルゼンチン） ・子宮筋腫治療装置の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：手術技術、腹腔鏡技術、アブレーション技術、塞栓術技術 ・用途別分析：侵襲的治療、低侵襲的治療、非侵襲的治療 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Uterine Fibroid Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Uterine Fibroid Treatment Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Uterine Fibroid Treatment Device market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Uterine Fibroid Treatment Device market has been segmented into:
Surgical Techniques
Laparoscopic Techniques
Ablation Techniques
Embolization Technique
By Application, Uterine Fibroid Treatment Device has been segmented into:
Invasive Treatment
Minimally Invasive Treatment
Non-invasive Treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Uterine Fibroid Treatment Device market presented in the report. This section sheds light on the sales growth of different regional and country-level Uterine Fibroid Treatment Device markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Uterine Fibroid Treatment Device market.
The report offers in-depth assessment of the growth and other aspects of the Uterine Fibroid Treatment Device market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Uterine Fibroid Treatment Device Market Share Analysis
Uterine Fibroid Treatment Device competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Uterine Fibroid Treatment Device sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Uterine Fibroid Treatment Device sales, revenue and market share for each player covered in this report.
The major players covered in Uterine Fibroid Treatment Device are:
Medtronic
Gynesonics
INSIGHTEC
Stryker Corporation
Lumenis
Boston Scientific Corporation
Shenzhen PRO HITU Medical
Hologic, Inc.
CooperSurgical Inc.
Chongqing Haifu Medical Technology
Among other players domestic and global, Uterine Fibroid Treatment Device market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Uterine Fibroid Treatment Device Market Overview
1.1 Product Overview and Scope of Uterine Fibroid Treatment Device
1.2 Classification of Uterine Fibroid Treatment Device by Type
1.2.1 Global Uterine Fibroid Treatment Device Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Uterine Fibroid Treatment Device Revenue Market Share by Type in 2019
1.2.3 Surgical Techniques
1.2.4 Laparoscopic Techniques
1.2.5 Ablation Techniques
1.2.6 Embolization Technique
1.3 Global Uterine Fibroid Treatment Device Market by Application
1.3.1 Overview: Global Uterine Fibroid Treatment Device Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Invasive Treatment
1.3.3 Minimally Invasive Treatment
1.3.4 Non-invasive Treatment
1.4 Global Uterine Fibroid Treatment Device Market by Regions
1.4.1 Global Uterine Fibroid Treatment Device Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Uterine Fibroid Treatment Device (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Uterine Fibroid Treatment Device Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Uterine Fibroid Treatment Device Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Uterine Fibroid Treatment Device Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Uterine Fibroid Treatment Device Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Uterine Fibroid Treatment Device Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gynesonics
2.2.1 Gynesonics Details
2.2.2 Gynesonics Major Business
2.2.3 Gynesonics SWOT Analysis
2.2.4 Gynesonics Product and Services
2.2.5 Gynesonics Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.3 INSIGHTEC
2.3.1 INSIGHTEC Details
2.3.2 INSIGHTEC Major Business
2.3.3 INSIGHTEC SWOT Analysis
2.3.4 INSIGHTEC Product and Services
2.3.5 INSIGHTEC Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.4 Stryker Corporation
2.4.1 Stryker Corporation Details
2.4.2 Stryker Corporation Major Business
2.4.3 Stryker Corporation SWOT Analysis
2.4.4 Stryker Corporation Product and Services
2.4.5 Stryker Corporation Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.5 Lumenis
2.5.1 Lumenis Details
2.5.2 Lumenis Major Business
2.5.3 Lumenis SWOT Analysis
2.5.4 Lumenis Product and Services
2.5.5 Lumenis Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boston Scientific Corporation
2.6.1 Boston Scientific Corporation Details
2.6.2 Boston Scientific Corporation Major Business
2.6.3 Boston Scientific Corporation Product and Services
2.6.4 Boston Scientific Corporation Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shenzhen PRO HITU Medical
2.7.1 Shenzhen PRO HITU Medical Details
2.7.2 Shenzhen PRO HITU Medical Major Business
2.7.3 Shenzhen PRO HITU Medical Product and Services
2.7.4 Shenzhen PRO HITU Medical Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hologic, Inc.
2.8.1 Hologic, Inc. Details
2.8.2 Hologic, Inc. Major Business
2.8.3 Hologic, Inc. Product and Services
2.8.4 Hologic, Inc. Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.9 CooperSurgical Inc.
2.9.1 CooperSurgical Inc. Details
2.9.2 CooperSurgical Inc. Major Business
2.9.3 CooperSurgical Inc. Product and Services
2.9.4 CooperSurgical Inc. Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
2.10 Chongqing Haifu Medical Technology
2.10.1 Chongqing Haifu Medical Technology Details
2.10.2 Chongqing Haifu Medical Technology Major Business
2.10.3 Chongqing Haifu Medical Technology Product and Services
2.10.4 Chongqing Haifu Medical Technology Uterine Fibroid Treatment Device Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Uterine Fibroid Treatment Device Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Uterine Fibroid Treatment Device Players Market Share
3.2.2 Top 10 Uterine Fibroid Treatment Device Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Uterine Fibroid Treatment Device Revenue and Market Share by Regions
4.2 North America Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
4.3 Europe Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
4.5 South America Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
5 North America Uterine Fibroid Treatment Device Revenue by Countries
5.1 North America Uterine Fibroid Treatment Device Revenue by Countries (2015-2020)
5.2 USA Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
5.3 Canada Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
5.4 Mexico Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
6 Europe Uterine Fibroid Treatment Device Revenue by Countries
6.1 Europe Uterine Fibroid Treatment Device Revenue by Countries (2015-2020)
6.2 Germany Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
6.3 UK Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
6.4 France Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
6.5 Russia Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
6.6 Italy Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Uterine Fibroid Treatment Device Revenue by Countries
7.1 Asia-Pacific Uterine Fibroid Treatment Device Revenue by Countries (2015-2020)
7.2 China Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
7.3 Japan Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
7.4 Korea Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
7.5 India Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
8 South America Uterine Fibroid Treatment Device Revenue by Countries
8.1 South America Uterine Fibroid Treatment Device Revenue by Countries (2015-2020)
8.2 Brazil Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
8.3 Argentina Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Uterine Fibroid Treatment Device by Countries
9.1 Middle East & Africa Uterine Fibroid Treatment Device Revenue by Countries (2015-2020)
9.2 Saudi Arabia Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
9.3 UAE Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
9.4 Egypt Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
9.5 South Africa Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Uterine Fibroid Treatment Device Revenue and Market Share by Type (2015-2020)
10.2 Global Uterine Fibroid Treatment Device Market Forecast by Type (2019-2024)
10.3 Surgical Techniques Revenue Growth Rate (2015-2025)
10.4 Laparoscopic Techniques Revenue Growth Rate (2015-2025)
10.5 Ablation Techniques Revenue Growth Rate (2015-2025)
10.6 Embolization Technique Revenue Growth Rate (2015-2025)
11 Global Uterine Fibroid Treatment Device Market Segment by Application
11.1 Global Uterine Fibroid Treatment Device Revenue Market Share by Application (2015-2020)
11.2 Uterine Fibroid Treatment Device Market Forecast by Application (2019-2024)
11.3 Invasive Treatment Revenue Growth (2015-2020)
11.4 Minimally Invasive Treatment Revenue Growth (2015-2020)
11.5 Non-invasive Treatment Revenue Growth (2015-2020)
12 Global Uterine Fibroid Treatment Device Market Size Forecast (2021-2025)
12.1 Global Uterine Fibroid Treatment Device Market Size Forecast (2021-2025)
12.2 Global Uterine Fibroid Treatment Device Market Forecast by Regions (2021-2025)
12.3 North America Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
12.4 Europe Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
12.6 South America Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Uterine Fibroid Treatment Device Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Uterine Fibroid Treatment Device by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Uterine Fibroid Treatment Device Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Uterine Fibroid Treatment Device Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Uterine Fibroid Treatment Device Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Medtronic Corporate Information, Location and Competitors
Table 7. Medtronic Uterine Fibroid Treatment Device Major Business
Table 8. Medtronic Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 9. Medtronic SWOT Analysis
Table 10. Medtronic Uterine Fibroid Treatment Device Product and Solutions
Table 11. Medtronic Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Gynesonics Corporate Information, Location and Competitors
Table 13. Gynesonics Uterine Fibroid Treatment Device Major Business
Table 14. Gynesonics Uterine Fibroid Treatment Device Total Revenue (USD Million) (2018-2019)
Table 15. Gynesonics SWOT Analysis
Table 16. Gynesonics Uterine Fibroid Treatment Device Product and Solutions
Table 17. Gynesonics Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. INSIGHTEC Corporate Information, Location and Competitors
Table 19. INSIGHTEC Uterine Fibroid Treatment Device Major Business
Table 20. INSIGHTEC Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 21. INSIGHTEC SWOT Analysis
Table 22. INSIGHTEC Uterine Fibroid Treatment Device Product and Solutions
Table 23. INSIGHTEC Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Stryker Corporation Corporate Information, Location and Competitors
Table 25. Stryker Corporation Uterine Fibroid Treatment Device Major Business
Table 26. Stryker Corporation Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 27. Stryker Corporation SWOT Analysis
Table 28. Stryker Corporation Uterine Fibroid Treatment Device Product and Solutions
Table 29. Stryker Corporation Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Lumenis Corporate Information, Location and Competitors
Table 31. Lumenis Uterine Fibroid Treatment Device Major Business
Table 32. Lumenis Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 33. Lumenis SWOT Analysis
Table 34. Lumenis Uterine Fibroid Treatment Device Product and Solutions
Table 35. Lumenis Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Boston Scientific Corporation Corporate Information, Location and Competitors
Table 37. Boston Scientific Corporation Uterine Fibroid Treatment Device Major Business
Table 38. Boston Scientific Corporation Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 39. Boston Scientific Corporation SWOT Analysis
Table 40. Boston Scientific Corporation Uterine Fibroid Treatment Device Product and Solutions
Table 41. Boston Scientific Corporation Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Shenzhen PRO HITU Medical Corporate Information, Location and Competitors
Table 43. Shenzhen PRO HITU Medical Uterine Fibroid Treatment Device Major Business
Table 44. Shenzhen PRO HITU Medical Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 45. Shenzhen PRO HITU Medical SWOT Analysis
Table 46. Shenzhen PRO HITU Medical Uterine Fibroid Treatment Device Product and Solutions
Table 47. Shenzhen PRO HITU Medical Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Hologic, Inc. Corporate Information, Location and Competitors
Table 49. Hologic, Inc. Uterine Fibroid Treatment Device Major Business
Table 50. Hologic, Inc. Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 51. Hologic, Inc. SWOT Analysis
Table 52. Hologic, Inc. Uterine Fibroid Treatment Device Product and Solutions
Table 53. Hologic, Inc. Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. CooperSurgical Inc. Corporate Information, Location and Competitors
Table 55. CooperSurgical Inc. Uterine Fibroid Treatment Device Major Business
Table 56. CooperSurgical Inc. Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 57. CooperSurgical Inc. SWOT Analysis
Table 58. CooperSurgical Inc. Uterine Fibroid Treatment Device Product and Solutions
Table 59. CooperSurgical Inc. Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Chongqing Haifu Medical Technology Corporate Information, Location and Competitors
Table 61. Chongqing Haifu Medical Technology Uterine Fibroid Treatment Device Major Business
Table 62. Chongqing Haifu Medical Technology Uterine Fibroid Treatment Device Total Revenue (USD Million) (2017-2018)
Table 63. Chongqing Haifu Medical Technology SWOT Analysis
Table 64. Chongqing Haifu Medical Technology Uterine Fibroid Treatment Device Product and Solutions
Table 65. Chongqing Haifu Medical Technology Uterine Fibroid Treatment Device Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Uterine Fibroid Treatment Device Revenue (Million USD) by Players (2015-2020)
Table 67. Global Uterine Fibroid Treatment Device Revenue Share by Players (2015-2020)
Table 68. Global Uterine Fibroid Treatment Device Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Uterine Fibroid Treatment Device Revenue Market Share by Regions (2015-2020)
Table 70. North America Uterine Fibroid Treatment Device Revenue by Countries (2015-2020)
Table 71. North America Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Table 72. Europe Uterine Fibroid Treatment Device Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Uterine Fibroid Treatment Device Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Uterine Fibroid Treatment Device Revenue by Countries (2015-2020)
Table 75. South America Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Uterine Fibroid Treatment Device Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Table 78. Global Uterine Fibroid Treatment Device Revenue (Million USD) by Type (2015-2020)
Table 79. Global Uterine Fibroid Treatment Device Revenue Share by Type (2015-2020)
Table 80. Global Uterine Fibroid Treatment Device Revenue Forecast by Type (2021-2025)
Table 81. Global Uterine Fibroid Treatment Device Revenue by Application (2015-2020)
Table 82. Global Uterine Fibroid Treatment Device Revenue Share by Application (2015-2020)
Table 83. Global Uterine Fibroid Treatment Device Revenue Forecast by Application (2021-2025)
Table 84. Global Uterine Fibroid Treatment Device Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Uterine Fibroid Treatment Device Picture
Figure 2. Global Uterine Fibroid Treatment Device Revenue Market Share by Type in 2019
Figure 3. Surgical Techniques Picture
Figure 4. Laparoscopic Techniques Picture
Figure 5. Ablation Techniques Picture
Figure 6. Embolization Technique Picture
Figure 7. Uterine Fibroid Treatment Device Revenue Market Share by Application in 2019
Figure 8. Invasive Treatment Picture
Figure 9. Minimally Invasive Treatment Picture
Figure 10. Non-invasive Treatment Picture
Figure 11. Global Uterine Fibroid Treatment Device Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Uterine Fibroid Treatment Device Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Uterine Fibroid Treatment Device Revenue Market Share in 2019
Figure 20. Global Top 10 Players Uterine Fibroid Treatment Device Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Uterine Fibroid Treatment Device Revenue Market Share by Regions (2015-2020)
Figure 24. Global Uterine Fibroid Treatment Device Revenue Market Share by Regions in 2018
Figure 25. North America Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 26. Europe Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 28. South America Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 30. North America Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Figure 31. North America Uterine Fibroid Treatment Device Revenue Market Share by Countries in 2019
Figure 32. USA Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 33. Canada Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 35. Europe Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Uterine Fibroid Treatment Device Revenue Market Share by Countries in 2019
Figure 37. Germany Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 38. UK Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 39. France Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 40. Russia Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 41. Italy Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Uterine Fibroid Treatment Device Revenue Market Share by Countries in 2019
Figure 44. China Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 45. Japan Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 46. Korea Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 47. India Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 49. South America Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Figure 50. South America Uterine Fibroid Treatment Device Revenue Market Share by Countries in 2019
Figure 51. Brazil Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Uterine Fibroid Treatment Device Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Uterine Fibroid Treatment Device Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 56. UAE Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Uterine Fibroid Treatment Device Revenue and Growth Rate (2015-2020)
Figure 59. Global Uterine Fibroid Treatment Device Revenue Share by Type (2015-2020)
Figure 60. Global Uterine Fibroid Treatment Device Revenue Share by Type in 2019
Figure 61. Global Uterine Fibroid Treatment Device Market Share Forecast by Type (2021-2025)
Figure 62. Global Surgical Techniques Revenue Growth Rate (2015-2020)
Figure 63. Global Laparoscopic Techniques Revenue Growth Rate (2015-2020)
Figure 64. Global Ablation Techniques Revenue Growth Rate (2015-2020)
Figure 65. Global Embolization Technique Revenue Growth Rate (2015-2020)
Figure 66. Global Uterine Fibroid Treatment Device Revenue Share by Application (2015-2020)
Figure 67. Global Uterine Fibroid Treatment Device Revenue Share by Application in 2019
Figure 68. Global Uterine Fibroid Treatment Device Market Share Forecast by Application (2021-2025)
Figure 69. Global Invasive Treatment Revenue Growth Rate (2015-2020)
Figure 70. Global Minimally Invasive Treatment Revenue Growth Rate (2015-2020)
Figure 71. Global Non-invasive Treatment Revenue Growth Rate (2015-2020)
Figure 72. Global Uterine Fibroid Treatment Device Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Uterine Fibroid Treatment Device Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Uterine Fibroid Treatment Device Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
Figure 76. Europe Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
Figure 78. South America Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Uterine Fibroid Treatment Device Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
子宮筋腫治療装置の世界市場（～2026年） Uterine fibroids are noncancerous growths of the uterus that often appear during childbearing years. Also called leiomyomas (lie-o-my-O-muhs) or myomas, uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer. Market Analysis and Insights: Glo…- 子宮筋腫塞栓術の世界市場（～2026年） Uterine fibroid embolization (UFE) is an effective, non-surgical method used to treat uterine fibroids in the fertile women population. It is performed with the help of uterine fibroid embolization agents, delivered to the tumor by micro-catheters. The embolization agents block the arteries supplyin…
- 子宮筋腫の世界市場（～2026年） Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasional…
- 子宮がん診断検査の世界市場（～2026年） Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth. In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer. Market Analysis and In…
- 子宮内膜ポリープ治療薬の世界市場（～2026年） Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign. Market Analysis and Insights: Global Uterine Polyps Drug Market The global Uterine Polyps Drug market size is projected to reach US$ XX million …